Clinical trial
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy
NCT03145298
Study timeline
Study start (actual)2017-10-01Date precision: day
Registry last updated2023-06-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Arterial Hypertension (PAH)unresolved
Interventions
PlaceboBIOLOGICAL
Sponsors & collaborators
Cedars-Sinai Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03145298 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.